Skip to Content

Doxercalciferol Pregnancy and Breastfeeding Warnings

Doxercalciferol is also known as: Hectorol

Medically reviewed on Jul 30, 2018

Doxercalciferol Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies showed no teratogenic or fetotoxic effects. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Doxercalciferol Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

-Other vitamin D derivatives are excreted in human milk.

See references

References for pregnancy information

  1. "Product Information. Hectorol (doxercalciferol)" Genzyme Corporation, Cambridge, MA.

References for breastfeeding information

  1. "Product Information. Hectorol (doxercalciferol)" Genzyme Corporation, Cambridge, MA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.